GLRE Greenlight Capital RE (GLRE) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0001385613
Form 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about GLRE
Insiders, 180 days
-$1.9M net sold
1 buyer · 5 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$384.2K
1 notice
Greenlight Capital RE insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, GREENLIGHT CAPITAL RE, LTD. insiders sold a net $1.9M of stock across 38 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 17 earlier Form 4 trades (code P or S) here by this insider (17 sales), the last on Sep 25, 2026.
- The trade is 13.6% of the 37,992 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Director Isaacs Ian sold about $76.7K of GLRE on Sep 28, 2026; 1 other insider sold within 30 days.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Sep 14, 2026.
- The trade is 23.2% of the 43,142 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Director Isaacs Ian sold about $149.5K of GLRE on Sep 25, 2026; 1 other insider sold within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 15.5% of the 86,879 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Controller Diaz Sherry sold about $203.6K of GLRE on Sep 17, 2026; 1 other insider sold within 30 days.Context
- 15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Aug 28, 2026.
- The trade is 9.1% of the 53,142 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Director Isaacs Ian sold about $73.4K of GLRE on Sep 14, 2026; 1 other insider sold within 30 days.Context
- 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Aug 27, 2026.
- The trade is 20.3% of the 20,000 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Director Isaacs Ian sold about $62.5K of GLRE on Aug 28, 2026; 1 other insider sold within 30 days.38 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$1.9M over 180 days
-$394.1K over 90 days
more than 57% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+4.8% year over year
below 65% of Insurance
Margin
10.3% net margin
more than 50% of Insurance
Buybacks
$19.2M repurchased, FY to 2026-06-30
below 86% of Insurance
Short interest
3.2% of the float short (float per yahoo 2026-10-26) · 5.3 days to cover · settled 2026-09-30
below 58% of Insurance
What changed in the last 30 days
Sep 29Director Isaacs Ian sold $226.3K (2 trades, Sep 25 to Sep 28)
Watch GLRE
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+23.2%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns GLRE: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in GLRE
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
GLRE planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Isaacs Ian
Filed 2026-08-25
$384.2K
Executive pay vs shareholder return · Simon Burton
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.3M
$2.8M
$1.3M
+99%
+134%
2024
$2.3M
$2.9M
$931.2K
+92%
+113%
2023
$5.9M
$7.3M
$993.3K
+56%
+57%
2022
$2.7M
$3.1M
$841.7K
+11%
+42%
2021
$3.1M
$3.0M
$1.2M
+7%
+19%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.9M sold by insiders over 180 days, $384.2K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
GLRE financials
Revenue growth
+4.8%
XBRL, annual
Net margin
10.3%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$683.5M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM GLRE
| FY Dec 2025 | $729.8M |
| FY Dec 2024 | $696.0M |
| FY Dec 2023 | $667.1M |
| FY Dec 2022 | $526.7M |
| FY Dec 2021 | $588.6M |
| Jun 2026 | $137.5M |
| Mar 2026 | $189.7M |
| Dec 2025 | $210.3M |
| Sep 2025 | $146.1M |
| Jun 2025 | $160.1M |
| Mar 2025 | $213.3M |
| Dec 2024 | $141.8M |
| Sep 2024 | $188.0M |
At each fiscal year end
Single quarter
Net margin, TTM
+7.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM GLRE
| FY Dec 2025 | +10.3% |
| FY Dec 2024 | +6.2% |
| FY Dec 2023 | +13.0% |
| FY Dec 2022 | +4.8% |
| FY Dec 2021 | +3.0% |
| Jun 2026 | -21.5% |
| Mar 2026 | +18.8% |
| Dec 2025 | +23.4% |
| Sep 2025 | -3.0% |
| Jun 2025 | +0.2% |
| Mar 2025 | +13.9% |
| Dec 2024 | -19.3% |
| Sep 2024 | +18.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$199.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM GLRE
| FY Dec 2025 | $209.8M |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | $31.4M |
| Mar 2026 | $37.2M |
| Dec 2025 | $100.0M |
| Sep 2025 | $30.9M |
| Jun 2025 | $68.4M |
| Mar 2025 | $10.4M |
| Dec 2024 | $28.5M |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.01x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity GLRE
| FY Dec 2025 | 0.01x |
| FY Dec 2024 | 0.10x |
| FY Dec 2023 | 0.12x |
| FY Dec 2022 | 0.16x |
| FY Dec 2021 | n/a |
| Jun 2026 | 0.01x |
| Mar 2026 | 0.01x |
| Dec 2025 | 0.01x |
| Sep 2025 | 0.05x |
| Jun 2025 | 0.09x |
| Mar 2025 | 0.09x |
| Dec 2024 | 0.10x |
| Sep 2024 | 0.09x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
22.86x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt GLRE
| FY Dec 2025 | 44.50x |
| FY Dec 2024 | 1.84x |
| FY Dec 2023 | 0.10x |
| FY Dec 2022 | -0.39x |
| FY Dec 2021 | n/a |
| Jun 2026 | 22.86x |
| Mar 2026 | 50.03x |
| Dec 2025 | 44.50x |
| Sep 2025 | 4.02x |
| Jun 2025 | 2.54x |
| Mar 2025 | 1.74x |
| Dec 2024 | 1.84x |
| Sep 2024 | 1.66x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity GLRE
| FY Dec 2025 | +11.1% |
| FY Dec 2024 | +7.0% |
| FY Dec 2023 | +15.8% |
| FY Dec 2022 | +5.2% |
| FY Dec 2021 | +3.7% |
| Jun 2026 | +7.5% |
| Mar 2026 | +11.5% |
| Dec 2025 | +11.1% |
| Sep 2025 | -0.3% |
| Jun 2025 | +5.8% |
| Mar 2025 | +7.0% |
| Dec 2024 | +7.0% |
| Sep 2024 | +14.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets GLRE
| FY Dec 2025 | +3.6% |
| FY Dec 2024 | +2.3% |
| FY Dec 2023 | +5.2% |
| FY Dec 2022 | +1.7% |
| FY Dec 2021 | +1.3% |
| Jun 2026 | +2.3% |
| Mar 2026 | +3.7% |
| Dec 2025 | +3.6% |
| Sep 2025 | -0.1% |
| Jun 2025 | +1.8% |
| Mar 2025 | +2.3% |
| Dec 2024 | +2.3% |
| Sep 2024 | +4.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital GLRE
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed GLRE
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.29x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing GLRE
| FY Dec 2025 | 6.72x |
| FY Dec 2024 | 11.29x |
| FY Dec 2023 | 4.78x |
| FY Dec 2022 | 12.54x |
| FY Dec 2021 | 15.68x |
| Jun 2026 | 11.08x |
| Mar 2026 | 7.33x |
| Dec 2025 | 6.72x |
| Sep 2025 | n/a |
| Jun 2025 | 13.06x |
| Mar 2025 | 10.27x |
| Dec 2024 | 11.29x |
| Sep 2024 | 5.40x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$422.7M
market value at close 2026-10-26 on 2026-08-03 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value GLRE
| FY Dec 2025 | $390.1M |
| FY Dec 2024 | $483.7M |
| FY Dec 2023 | $425.8M |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | $469.1M |
| Mar 2026 | $517.2M |
| Dec 2025 | $390.1M |
| Sep 2025 | $400.3M |
| Jun 2025 | $473.1M |
| Mar 2025 | $480.7M |
| Dec 2024 | $483.7M |
| Sep 2024 | $490.1M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+40.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield GLRE
| FY Dec 2025 | +42.2% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | +37.2% |
| Mar 2026 | +40.3% |
| Dec 2025 | +42.2% |
| Sep 2025 | +31.8% |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.31x
P/E over trailing EPS growth of 33%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing GLRE
| FY Dec 2025 | 0.09x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 0.02x |
| FY Dec 2022 | 0.42x |
| FY Dec 2021 | 0.07x |
| Jun 2026 | 0.34x |
| Mar 2026 | 0.09x |
| Dec 2025 | 0.09x |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $729.8M | $696.0M | $667.1M | $526.7M |
| Net income | $74.8M | $42.8M | $86.8M | $25.3M |
| EPS (diluted) | 2.17 | 1.24 | 2.50 | 0.73 |
| Operating cash flow | $210.2M | $111.5M | $7.5M | -$31.8M |
| Cash | $111.8M | $64.7M | $51.1M | $38.2M |
| Long-term debt | $4.7M | $60.7M | $73.3M | $80.5M |
| Buybacks | $9.8M | $7.5M | $0 | $35.0K |
SEC XBRL, fiscal years, as known on 2026-10-28
GLRE Stock Sonar score 5/7 axes
Find similar shapesCompareGLRE ranks highest on financial health (94th percentile) and risk and compliance (68th), and lowest on profitability (34th), among Insurance peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GLRE filings, in plain words
Are Greenlight Capital RE insiders buying or selling GLRE?
In the 180 days to 2026-10-28, Greenlight Capital RE insiders were net sellers, a net $1.9M: $186.2K of purchases and $2.1M of sales reported on Form 4, by 1 buyer and 5 sellers.
Are there planned insider sales of GLRE?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $384.2K of stock; the latest, by Isaacs Ian, was filed 2026-08-25.
Read the full summary
In the 180 days to 2026-10-28, Greenlight Capital RE insiders were net sellers of GLRE, a net $1.9M across purchases and sales reported on Form 4 by 1 buyer and 5 sellers. Sales outweighed purchases more than tenfold by value. None of the 18 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $384.2K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
